Document Detail

Clinical experience of coenzyme Q10 to enhance intraoperative myocardial protection in coronary artery revascularization.
MedLine Citation:
PMID:  1854669     Owner:  NLM     Status:  MEDLINE    
Seventy-eight patients undergoing coronary artery bypass grafting (CABG) were compared retrospectively to evaluate whether pretreatment with coenzyme Q10 (CoQ) is effective in preventing left ventricular depression in early reperfusion following CABG. CoQ (5 mg/kg, intravenously) was given to 60 patients, 2 hours prior to the onset of cardiopulmonary bypass (CPB). CABG was performed using saphenous vein under CPB associated with cold cardioplegia in the standard fashion. Heart rate, mean arterial pressure, and cardiac index showed no significant difference between the CoQ and control groups. However, left ventricular stroke work index was significantly elevated at 6 and 10 hours of reperfusion following CABG in the CoQ-treated group compared with the controls. Serum MB-CK was lower at 0 and 6 hours of reperfusion in the CoQ group compared with the controls. These results suggest that pretreatment with intravenous CoQ is effective in preventing left ventricular depression in early reperfusion and in minimizing myocardial cellular injury during CABG followed by reperfusion.
M Sunamori; H Tanaka; T Maruyama; I Sultan; T Sakamoto; A Suzuki
Related Documents :
11222469 - Similarity of ventricular function in patients alive 5 years after randomization to sur...
15226989 - Aggressive surgical management of post-infarction angina: results of myocardial revascu...
23884199 - Characterization of anatomic ventricular tachycardia isthmus pathology after surgical r...
16678599 - Impact of preoperative treatment strategies on the early perioperative outcome in neona...
16305849 - Impact of unstable angina on outcomes of transmyocardial laser revascularization combin...
18782699 - Early and midterm results of off-pump coronary artery bypass grafting without patient s...
7706629 - Immediate and long-term survival after intra-aortic balloon pumping: is advanced age an...
8853319 - Reflex vagal control of atrial repolarization.
3152969 - Anthracycline-induced congestive heart failure in two pediatric leukemia cases and long...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy     Volume:  5 Suppl 2     ISSN:  0920-3206     ISO Abbreviation:  Cardiovasc Drugs Ther     Publication Date:  1991 Mar 
Date Detail:
Created Date:  1991-08-29     Completed Date:  1991-08-29     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8712220     Medline TA:  Cardiovasc Drugs Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  297-300     Citation Subset:  IM    
Department of Thoracic-Cardiovascular Surgery, Tokyo Medical and Dental University, School of Medicine, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Coronary Artery Bypass / adverse effects*
Hemodynamics / drug effects
Infusions, Intravenous
Intraoperative Care*
Middle Aged
Myocardial Reperfusion Injury / enzymology,  etiology,  prevention & control*
Retrospective Studies
Ubiquinone / therapeutic use*
Reg. No./Substance:
0/Coenzymes; 1339-63-5/Ubiquinone; 303-98-0/coenzyme Q10

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The occurrence of oxidative stress during reperfusion in experimental animals and men.
Next Document:  Effect of orally administered alpha-tocopheryl acetate on human myocardial alpha-tocopherol levels.